Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Carna Biosciences's operating assets for the quarter that ended in Dec. 2025 was 円712.9 Mil. Carna Biosciences's operating liabilities for the quarter that ended in Dec. 2025 was 円205.9 Mil. Carna Biosciences's Total Assets for the quarter that ended in Jun. 2025 was 円1,635.6 Mil. Therefore, Carna Biosciences's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2025 was 0.31.
Carna Biosciences Scaled Net Operating Assets Related Terms
Carna Biosciences Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Carna Biosciences's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carna Biosciences Scaled Net Operating Assets Chart
TSE:4572 vs VRTX, REGN, ALNY: Scaled Net Operating Assets Comparison
For the Biotechnology subindustry, Carna Biosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carna Biosciences Scaled Net Operating Assets vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Carna Biosciences's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Carna Biosciences's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.31 mean?
Carna Biosciences (TSE:4572) has a Scaled Net Operating Assets of 0.31 as of Dec. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Carna Biosciences and its competitors.
Is Carna Biosciences' Scaled Net Operating Assets too high?
Carna Biosciences' current Scaled Net Operating Assets is 0.31. Overall, Carna Biosciences has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Scaled Net Operating Assets compare to VRTX and REGN?
Carna Biosciences' Scaled Net Operating Assets of 0.31 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current Scaled Net Operating Assets is 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円174.85, compared to a current price of 円337.00 — trading 92.7% above its estimated fair value. The current Scaled Net Operating Assets is 0.31. Carna Biosciences' overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Scaled Net Operating Assets is 0.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carna Biosciences (TSE:4572) Overvalued in 2026?
Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued.
The current stock price of 円337.00 is trading 92.7% above its estimated GF Value™ of 円174.85.
GuruFocus considers Carna Biosciences to be Significantly Overvalued.
Key valuation signals for TSE:4572:
Scaled Net Operating Assets: 0.31
GF Value™: 円174.85 vs. price of 円337.00 (92.7% above fair value)
No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
24GF Score
Get the complete analysis for TSE:4572
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4572 has been successfully added to your 
